FDA•
Gas-X Extra Strength Softgels
Haleon is recalling Gas-X Extra Strength Softgels distributed nationwide due to potential chemical contamination.
Filters
Category
Agency
Severity
Drugs Recalls
Back to home ←
FDA•MODERATEKirkland Signature Ultra Strength AntacidGuardian Drug is recalling Kirkland Signature Ultra Strength Antacid tablets due to potential metallic particle contamination.
23 products
FDA•Niacin Extended-release TabletsLannett is recalling 1,000 mg Niacin Extended-release Tablets due to failed dissolution specifications.
FDA•Xyvona (levorphanol tartrate) 2mg TabletsForte BioPharma is recalling Xyvona (levorphanol tartrate) 2mg tablets due to the FDA's denial of the product's proprietary name.
2 products
FDA•LOWPred Mild Ophthalmic SuspensionAbbVie is recalling 10 mL bottles of Pred Mild ophthalmic suspension due to failed stability specifications.
FDA•LOWLidocaine HCl Injection 2%Eugia US LLC is recalling Lidocaine HCl Injection 2% single-dose vials because the label wrap obscures the barcode, preventing it from scanning.
FDA•ToxiBan Charcoal-Kaolin SuspensionLloyd Inc. is recalling ToxiBan Charcoal-Kaolin Suspension due to microbial levels exceeding specification limits.
FDA•LOWNicotine Transdermal System Patch 14 mgAveva is recalling 14 mg Nicotine Transdermal System Patches due to elevated levels of oxidative-related impurities.
FDA•MODERATEDuloxetine DR Capsules 30 mgAsclemed USA is recalling Duloxetine DR Capsules 30 mg due to the presence of a nitrosamine impurity above acceptable intake limits.
FDA•Aisling Doxorubicin Hydrochloride Liposome InjectionSun Pharma is recalling Aisling Doxorubicin Hydrochloride Liposome Injection 50mg/25 mL nationwide due to potential glass particle contamination.
FDA•MODERATEEstradiol Gel 0.1% PacketsANI Pharmaceuticals is recalling Estradiol Gel 0.1% packets due to a defective container issue resulting in empty or partially full packets.
FDA•MODERATEFentanyl Citrate Sterile CADD for InjectionIntegraDose is recalling Fentanyl Citrate Sterile CADD for Injection due to subpotency.
FDA•MODERATELidocaine HCl Injection USPSpectra Medical Devices is recalling Lidocaine HCl Injection USP single-dose ampules due to a lack of assurance of sterility.
FDA•MODERATEGas-X Simethicone 125 mg SoftGelsHaleon is recalling Gas-X Simethicone 125 mg SoftGels (120 count), UPC 3 00674 35041 9, due to incomplete inactive ingredient labeling.
FDA•MG217 Multi-symptom Treatment CreamPharmacal is recalling 6oz tubes of MG217 Multi-symptom Treatment Cream due to Staphylococcus aureus contamination.
FDA•MODERATECimzia Prefilled SyringesUCB is recalling Cimzia prefilled syringes and starter kits due to a lack of assurance of sterility.
FDA•MODERATEAmlodipine and Olmesartan Medoxomil TabletsAscend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, due to failed dissolution specifications.
FDA•LOWBusulfan InjectionSagent Pharmaceuticals is recalling Busulfan Injection (NDC 25021-241-10) due to failed impurities and degradation specifications.
FDA•LOWPrimidone Tablets 250 mgAmerican Health Packaging is recalling Primidone Tablets 250 mg due to cross-contamination with trace amounts of Acemetacin.
2 products
FDA•MODERATENephronex Vitamin B-Complex, Vitamin C & Folic Acid LiquidSafecor Health is recalling Nephronex oral liquid supplement due to foreign substance contamination from observed black particles.
FDA•MODERATEOphthavet Ophthalmic SolutionDechra is recalling Ophthavet Ophthalmic Solution for dogs and cats due to a lack of sterility assurance.
FDA•MODERATEAtomoxetine HCl 10mg CapsulesSafecor is recalling Atomoxetine HCl 10mg Capsules (NDC 64380-474-01) because some cartons may contain 25mg capsules due to a labeling error.
- FDA•MODERATEDuloxetine Delayed-Release Capsules 30 mg
Ajanta Pharma is recalling Duloxetine 30 mg capsules due to the presence of an N-nitroso-Duloxetine impurity above recommended safety limits.
3 products 
FDA•MODERATEErythromycin 250 mg TabletsZydus is recalling Erythromycin 250 mg tablets due to the presence of N-Nitroso-Desmethyl-Erythromycin above acceptable intake limits.
2 products
FDA•CRITICALLactated Ringer's Injection USPB. Braun Medical is recalling Lactated Ringer's Injection USP due to the presence of particulate matter.
FDA•MODERATEOasis Tears PF Lubricant Eye DropsOasis Tears PF eye drops (NDC 42126-6400-1) recalled due to lack of assurance of sterility.
FDA•MODERATEMetoprolol Succinate Extended-Release Tablets 25 mgAscend Laboratories is recalling 25 mg Metoprolol Succinate Extended-Release Tablets due to failed dissolution testing.
FDA•LOWPrimidone 50 mg TabletsGolden State Medical Supply is recalling Primidone 50 mg Tablets (NDC 51407-637-05) due to potential cross-contamination with Acemetacin.
2 products
FDA•MODERATEAmoxicillin and Clavulanate Potassium Oral Suspension DropsCronus Pharma is recalling Amoxicillin and Clavulanate Potassium oral suspension drops for dogs and cats due to product discoloration.
2 products
FDA•MODERATEOctreotide Acetate Injectable Suspension 30 mgTeva is recalling Octreotide Acetate 30 mg injectable suspension kits (NDC 0480-9262-08) due to sterility assurance concerns from manufacturing deficiencies.
2 products- FDA•LOWPrimidone 250mg Tablets
Lannett Company is recalling Primidone 250mg Tablets (NDC 0527-1231-01) due to potential cross-contamination with Acemetacin API.
- FDA•CRITICALMG217 Multi-Symptom Treatment Cream
Wisconsin Pharmacal is recalling MG217 Multi-Symptom Treatment Cream due to Staphylococcus aureus contamination.
FDA•MODERATELiraglutide InjectionLupin is recalling Liraglutide Injection (NDC 70748-346-02 and 70748-346-03) due to white thread-like particulate matter in the cartridge.
FDA•MODERATEiVIZIA Sterile Lubricant Eye DropsThea Pharma is recalling iVIZIA Sterile Lubricant Eye Drops due to a lack of assurance of sterility.
2 products
FDA•MODERATEEnalapril Maleate Tablets, USP 20 mgRising Pharma is recalling Enalapril Maleate 20 mg tablets (NDC 64980-688-10) due to failed impurities test.
FDA•MODERATEBD PurPrep Sterile SolutionCareFusion is recalling BD PurPrep sterile solution distributed nationwide due to potential contamination and lack of sterility assurance.
2 products
FDA•MODERATESystane Lubricant Eye GelAlcon is recalling Systane Lubricant Eye Gel due to a lack of assurance of sterility.
2 products
FDA•MODERATEDuloxetine Delayed-Release Capsules USP 60mgBreckenridge Pharmaceutical recalls Duloxetine 60mg capsules (NDC 51991-748-90) due to elevated N-nitroso impurity from manufacturing deviations.
FDA•MODERATEOptase Dry Eye Intense DropsScope Health is recalling Optase Dry Eye Intense Drops (0.33 fl oz, NDC 72972-002-01) due to lack of assurance of sterility.
FDA•MODERATENaproxen Oral Suspension USP 125 mg/5mLAcella Pharmaceuticals is recalling Naproxen Oral Suspension 125 mg/5mL (NDC 42192-619-16) due to lead and lithium contamination above specification.
FDA•CRITICALHeritage Animal Nutrition Medicated FeedHeritage Animal Nutrition is recalling 50 lb bags of medicated feed due to potential rumensin contamination.
FDA•MODERATEFreshKote Lubricant EyedropsHarrow Eye LLC is recalling FreshKote Lubricant Eyedrops (0.33 fl oz) due to lack of assurance of sterility.
FDA•LOWLevocarnitine Injection, USP 1 g/5 mLAmerican Regent is recalling Levocarnitine Injection 1 g/5 mL vials (NDC 0517-1045-01) due to missing label.
FDA•LOWMonsel's Ferric Subsulfate Solution 8 mLPremier Dental Products is recalling Monsel's Ferric Subsulfate Solution 8 mL vials (NDC 48783-112-08) due to incorrect expiration date on the vial label.
FDA•LOWBuspirone Hydrochloride Tablets 5 mgUnichem is recalling 500-count bottles of Buspirone Hydrochloride Tablets, 5 mg, due to subpotency.
FDA•MODERATEOmega-3-Acid Ethyl Esters Capsules 1 gramMajor Pharmaceuticals is recalling Omega-3-Acid Ethyl Esters Capsules 1 gram (NDC 0904-7495-06) due to failed capsule shell specifications.
FDA•Revitaderm and Tridergel Antiseptic Wound Care GelBlaine Labs is recalling Revitaderm and Tridergel antiseptic wound care gels due to potential contamination with Lysinibacillus fusiformis.
FDA•MODERATEDesmopressin Nasal Spray, USP 10 mcg/0.1 mLApotex is recalling Desmopressin Nasal Spray (NDC 60505-0815-0) due to defective bottle caps with missing or dislodged liners.
3 products
FDA•MODERATEAlendronate Sodium Oral Solution 70 mg/75 mLHikma is recalling Alendronate Sodium Oral Solution 70 mg/75 mL (NDC 0054-0282-59) due to out-of-specification assay results.
FDA•LOWCVS Lidocaine Wound GelCVS is recalling Lidocaine Wound Gel (NDC 59898-950, 0.5 oz) due to failed pH specifications.